UBS Group
TBIO

UBS Group’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

UBS Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,456
Closed -$8.96K – 10330
2024
Q2 		$8.96K Buy
2,456
+80
+3% +$417 ﹤0.01% 7768
2024
Q1 		$18.8K Buy
2,376
+2,360
+14,750% +$17.7K ﹤0.01% 6952
2023
Q4 		$117 Hold
16
– – ﹤0.01% 8906
2023
Q3 		$304 Buy
16
+1
+7% +$24 ﹤0.01% 8602
2023
Q2 		$430 Hold
15
– – ﹤0.01% 8240
2023
Q1 		$843 Sell
15
-193
-93% -$6.83K ﹤0.01% 8888
2022
Q4 		$4.5K Buy
208
+206
+10,300% +$5.6K ﹤0.01% 9328
2022
Q3 		$0 Sell
2
-341
-99% -$12K ﹤0.01% 11137
2022
Q2 		$11K Buy
+343
New +$23.7K ﹤0.01% 7868
2022
Q1 		– Sell
-157
Closed -$31K – 11091
2021
Q4 		$31K Buy
+157
New +$24.4K ﹤0.01% 7375
2021
Q3 		– Sell
-35
Closed -$14K – 10237
2021
Q2 		$14K Buy
+35
New +$12.4K ﹤0.01% 7726

Other funds holding TBIO

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group's TBIO Position: Q3 2024 in Review

UBS Group sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2024, closing a stake of 2,456 shares — an estimated $8.96K sold.

UBS Group first reported a position in TBIO in Q2 2021 and held it in 11 quarters. The position peaked at $31K in Q4 2021. 1 fund tracked by Wall St. Rank holds TBIO as of Q3 2024.

  • UBS Group reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 2,456 Telesis Bio, Inc. Common Stock shares in Q3 2024, an estimated $8.96K.
  • UBS Group first reported a position in Telesis Bio, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • UBS Group's Telesis Bio, Inc. Common Stock position peaked at $31K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.